Weight Loss Drugs

• Health Canada approves country’s 1st generic version of Ozempic

  The injectable semaglutide medication is manufactured by Dr. Reddy's Laboratories in India and is approved for the once-weekly treatment of Type 2 diabetes in adults.

  Health

  Apr 28
  
• Novo Nordisk says generic Ozempic, Wegovy will slow sales in Canada

  Novo Nordisk says the expiration of its patents for some semaglutide GLP-1 drug treatments in markets like Canada will result in more generics and hurt sales.

  Health

  Feb 4
  
• Advertisement
• Wegovy weight loss pill is now available for sale in U.S.

  The pill was approved by the U.S. Food and Drug Administration last month, a boon to Novo Nordisk as it looks to regain ground lost to U.S. rival Eli Lilly.

  Health

  Jan 6
• Advertisement
• U.S. FDA approves Wegovy weight-loss pill in industry first

  The approval gives Novo Nordisk a leg up in the race to market a potent oral medication for shedding pounds as it looks to regain lost ground from rival Eli Lilly.

  Health

  Dec 22, 2025
• Wegovy won’t be in Canadian public drug plans as Novo Nordisk refuses talks

  Negotiations that could have led to coverage for weight-loss drug Wegovy under Canadian public health plans are not moving forward.

  Health

  Dec 3, 2025
• Trump says prices for Ozempic, other weight-loss drugs to drop in U.S.

  Trump, Eli Lilly and Novo Nordisk unveiled a deal to slash the prices of popular GLP-1 weight‑loss drugs for government health insurance programs, as well as for cash payers.

  U.S. News

  Nov 6, 2025
• Weight-loss drug Wegovy use is up 50% among U.S. teens, study shows

  A new report from health data firm Truveta shows there was 50 per cent increase in American teenagers using the weight-loss drug Wegovy, particularly those living with obesity.

  Health

  Jun 3, 2025
• Drugs like Ozempic may lower cancer risk if you have diabetes: study

  Excess body weight can raise the risk of certain cancers, leading researchers to wonder whether drugs like Wegovy, Ozempic and Zepbound could play a role in cancer prevention.

  Health

  May 23, 2025
• Advertisement
• The Ozempic debate: Large study reveals the good and the bad

  A new study shows that GLP-1 drugs offer health benefits such as reducing risks for heart disease but also carry potential risks like gastrointestinal issues.

  Health

  Jan 21, 2025
• Advertisement
• Biden proposes coverage for weight-loss drugs for millions of obese Americans

  While the rule would give millions of people access to weekly injectables that have helped people shed pounds, it would cost taxpayers as much as $35 billion over the next decade.

  Health

  Nov 26, 2024